Related Experiment Video
Updated: Aug 12, 2026

Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
Published on: April 1, 2018
Developmental timing of exposure to elevated levels of phenylalanine is associated with ADHD symptom expression
Kevin M Antshel1, Susan E Waisbren
1Children's Hospital-Boston, Division of Psychology, Department of Psychiatry, Harvard Medical School, Longwood Avenue, Boston, Massachusetts, USA. antshelk@upstate.edu
Insights
Timing of phenylalanine exposure impacts attention deficit hyperactivity disorder (ADHD) symptoms. Prenatal exposure links to hyperactivity/impulsivity, while postnatal exposure is associated with inattentive symptoms in children with Phenylketonuria (PKU) and Maternal PKU (MPKU).
Area of Science:
- Neuroscience
- Developmental Pediatrics
- Metabolic Disorders
Background:
- Attention deficit hyperactivity disorder (ADHD) is a complex neurodevelopmental disorder.
- Elevated phenylalanine levels are a known biological insult.
- The timing of exposure to biological insults may influence neurodevelopmental outcomes.
Purpose of the Study:
- To investigate the association between the timing of elevated phenylalanine exposure and ADHD symptom presentation.
- To compare ADHD symptom profiles in children with Phenylketonuria (PKU) and Maternal PKU (MPKU).
- To examine the dose-dependent effects of phenylalanine on ADHD symptoms.
Main Methods:
- Comparative study design.
- Inclusion of children with Phenylketonuria (PKU) (postnatal exposure) and Maternal PKU (MPKU) (prenatal exposure).
- Inclusion of non-hyperphenylalaninemic siblings as controls.
Main Results:
- Elevated phenylalanine levels are associated with ADHD symptoms.
- Prenatal phenylalanine exposure (MPKU) is linked to a higher likelihood of hyperactive/impulsive symptoms.
- Postnatal phenylalanine exposure (PKU) is linked to a higher likelihood of inattentive symptoms.
- Phenylalanine toxicity is dose-dependent, with higher levels being more detrimental.
Conclusions:
- The timing of phenylalanine exposure significantly influences the manifestation of ADHD symptoms.
- Prenatal and postnatal phenylalanine exposure present distinct ADHD symptom profiles.
- Management of phenylalanine levels is crucial for mitigating neurodevelopmental risks associated with ADHD.
Abstract:
This study addresses attention deficit hyperactivity disorder (ADHD), with a focus on how the timing of a known biological insult affects ADHD symptom expression. The sample consists of children exposed to elevated levels of phenylalanine, either postnatally as in Phenylketonuria (PKU; n = 46) or prenatally as in Maternal PKU (MPKU; n = 15). Non-hyperphenylalaninemic siblings of children with PKU (n = 18) serve as controls. Results indicate that elevated levels of phenylalanine are associated with ADHD symptoms. The manifestations of the symptom expression are dependent on exposure timing: prenatal exposure is associated with a higher likelihood of expressing hyperactive/impulsive symptoms and postnatal exposure is associated with a higher likelihood of expressing inattentive symptoms. This toxicity is dose-dependent and higher levels of phenylalanine appear more detrimental.
More Related Videos
10:02Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Published on: March 12, 2020
05:44Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1
Published on: May 17, 2024
Related Concept Videos
Drug Toxicity: Risk factors
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Oppositional Defiant Disorder
Diagnostic Criteria and...
Conduct Disorder